Pharmacokinetics and Tissue Distribution of Vinorelbine Bitartrate after Intraveous Administration of Liposomal and Injectable Formulations

A hydrophilic and temperature-induced degradation drug, vinorelbine bitartrate (VB)-loaded phosphatidylethanolamin liposomes (PSLs), was prepared by the thin-film hydration method. Liposomes were made of phosphatidylethanolamine: cholesteryl: oleic acid (PE: CHOL: OA, 3:3:1 mass/mass). The mean particle size of the PSLs ranged from 293.06 nm. The transmission electron microscope (TEM) images displayed that the shape of the PSLs was multilamellar vesicles with smooth surface. The highest entrapment efficiency (EE) and drug loading capacity (DL) could reach up to 68.5% and 6.23%, respectively. The PSLs was evaluated by comparing the rate of release of encapsulated VB in different phosphate buffer solution (PBS), and the result showed that the rate of drug release in acid medium was faster than in pH 7.4. Pharmacokinetic characteristics in vivo and the tissue distribution in mice were investigated, which provided experimental and theoretical basis for utilizing liposomes in malignant tumor chemotherapy.     

Encapsulation of Mithramycin in Liposomes in Response to a Transmembrane Gradient of Calcium Ions

The recent discovery that mithramycin(MTR) in aqueous solution forms a high affinity[Ca(MTR)4]2- complex led us to the idea thatCa2+-loaded liposomes might be able to accumulateMTR in their aqueous internal compartment. Wetherefore investigated the uptake of MTR into largeunilamellar vesicles (LUV) containing NaCl orCaCl2. Our data show that MTR was efficientlyaccumulated within LUV made fromdipalmitoylphosphatidylcholine and cholesterol, onlywhen the liposomes contained Ca2+ and wereresuspended in a Ca2+-free medium. A drugencapsulation efficiency as high as 60% was achieved,at a drug to lipid molar ratio of 1/18. The circulardichroism and fluorescence excitation spectra ofliposome-encapsulated MTR (LMTR) displayed strongsimilarities with those of the [Ca(MTR)4]2-complex. LMTR was found to be stable, when submittedto conditions that destabilized the[Ca(MTR)4]2- complex. Upon dilution andincubation for 24 h at 37 °C, MTR-containingliposomes did not release a significant amount of MTR.These properties were attributed to the formation ofa high affinity complex between MTR and Ca2+inthe aqueous compartment of liposomes.     

A Comparison Investigation of Coix Seed Oil Liposomes Prepared by Five Different Methods

The physicochemical properties of coix seed oil (CSO) liposomes prepared by five different methods were evaluated for morphology, encapsulating efficiency, particle size, storage stability, and in vitro release. The different preparation methods resulted in several types of vesicles with different properties. The type of vesicles was closely related to leakage pattern, which affected the storage stability and in vitro release profiles. Ethanol injection method was the best choice for preparing safe and stable liposomes with controlled release. The release mechanisms might account for the diffusion of CSO, and Higuchi was the most suitable model for liposomes stored at high temperature or released in simulated intestinal fluid (SIF).     

Controlled Release of Encapsulated Bioactive Volatiles by Rupture of the Capsule Wall through the Light‐Induced Generation of a Gas

The encapsulation of photolabile 2‐oxoacetates in core–shell microcapsules allows the light‐induced, controlled release of bioactive compounds. On irradiation with UVA light these compounds degrade to generate an overpressure of gas inside the capsules, which expands or breaks the capsule wall. Headspace measurements confirmed the light‐induced formation of CO and CO₂ and the successful release of the bioactive compound, while optical microscopy demonstrated the formation of gas bubbles, the cleavage of the capsule wall, and the leakage of the oil phase out of the capsule. The efficiency of the delivery system depends on the structure of the 2‐oxoacetate, the quantity used with respect to the thickness of the capsule wall, and the intensity of the irradiating UVA light.     

亮氨酸拉链型脂肽对脂质体温敏性调节的分子模拟

含亮氨酸拉链型脂肽的温敏性脂质体被认为是抗癌药物的优良载体。亮氨酸拉链型脂肽的主要氨基酸残基序列为[VAQLEVK-VAQLESK-VSKLESK-VSSLESK],嵌入脂质体后可以有效改善脂质体的温敏性。本文首先采用隐式溶剂副本交换分子动力学方法,对N端修饰的亮氨酸拉链单链的折叠状态进行了模拟,得到了亮氨酸拉链单链的转变温度。并对包含该种新型亮氨酸拉链型脂肽的DPPC脂质体进行常规分子动力学模拟,研究了2种不同头基的亮氨酸拉链型脂肽(ALA,C3CO)二聚体嵌入后DPPC脂质体的相转变温度变化,证明了亮氨酸拉链型脂肽对于该脂质体温敏性的控制作用。利用这一规律,可以对亮氨酸拉链型脂肽进行优化改良,得到效果更佳的温敏脂质体,对于抗癌药物载体的开发有着重要的意义。     

Controlled Release of a Sparingly Water‐Soluble Anticancer Drug through pH‐Responsive Functionalized Gold‐Nanoparticle‐Decorated Liposomes

The binding and detachment of carboxyl‐modified gold nanoparticles from liposomes is used for controlled drug delivery. This study reveals that the binding and detachment of nanoparticles from liposomes depends on the degree of hydration of the liposomes. Liposomes with a lower hydration level undergo stronger electrostatic interactions with negatively charged gold nanoparticles, thus leading to a slower detachment of the carboxyl‐modified gold nanoparticles under gastric conditions. Therefore, under gastric conditions, gold‐nanoparticle‐decorated dipalmitoylphosphatidylcholine (DPPC) liposomes exhibit an at least ten‐times‐slower drug release compared to gold‐nanoparticle‐decorated 1,2‐dimyristoyl‐sn‐glycero‐3‐phosphocholine (DMPC) liposomes, although both liposomes in the bare state fail to pursue controlled release. Our study also reveals that one can modulate the drug‐release rate by simply varying the concentration of nanoparticles. This study highlights a novel strategy for the controlled release of drug molecules from liposomes.     

Encapsulation of α-Pinene in Delivery Systems Based on Liposomes and Cyclodextrins

The essential oil component α-pinene has multiple biological activities. However, its application is limited owing to its volatility, low aqueous solubility, and chemical instability. For the aim of improving its physicochemical properties, α-pinene was encapsulated in conventional liposomes (CLs) and drug-in-cyclodextrin-in-liposomes (DCLs). Hydroxypropyl-β-cyclodextrin/α-pinene (HP-β-CD/α-pinene) inclusion complexes were prepared in aqueous solution, and the optimal solubilization of α-pinene occurred at HP-β-CD:α-pinene molar ratio of 7.5:1. The ethanol-injection method was applied to produce different formulations using saturated (Phospholipon 90H) or unsaturated (Lipoid S100) phospholipids in combination with cholesterol. The size, the phospholipid and cholesterol incorporation rates, the encapsulation efficiency (EE), and the loading rate (LR) of α-pinene were determined, and the storage stability of liposomes was assessed. The results showed that α-pinene was efficiently entrapped in CLs and DCLs with high EE values. Moreover, Lipoid S100 CLs displayed the highest LR (22.9 ± 2.2%) of α-pinene compared to the other formulations. Both carrier systems HP-β-CD/α-pinene inclusion complex and Lipoid S100 CLs presented a gradual release of α-pinene. Furthermore, the DPPH radical scavenging activity of α-pinene was maintained upon encapsulation in Lipoid S100 CLs. Finally, it was found that all formulations were stable after three months of storage at 4 °C.     

Quality-by-Design-Based Development of n-Propyl-Gallate-Loaded Hyaluronic-Acid-Coated Liposomes for Intranasal Administration

The present study aimed to develop n-propyl gallate (PG)-encapsulated liposomes through a novel direct pouring method using the quality-by-design (QbD) approach. A further aim was to coat liposomes with hyaluronic acid (HA) to improve the stability of the formulation in nasal mucosa. The QbD method was used for the determination of critical quality attributes in the formulation of PG-loaded liposomes coated with HA. The optimized formulation was determined by applying the Box–Behnken design to investigate the effect of composition and process variables on particle size, polydispersity index (PDI), and zeta potential. Physiochemical characterization, in vitro release, and permeability tests, as well as accelerated stability studies, were performed with the optimized liposomal formulation. The optimized formulation resulted in 90 ± 3.6% encapsulation efficiency, 167.9 ± 3.5 nm average hydrodynamic diameter, 0.129 ± 0.002 PDI, and −33.9 ± 4.5 zeta potential. Coated liposomes showed significantly improved properties in 24 h in an in vitro release test (>60%), in vitro permeability measurement (420 μg/cm²) within 60 min, and also in accelerated stability studies compared to uncoated liposomes. A hydrogen-peroxide-scavenging assay showed improved stability of PG-containing liposomes. It can be concluded that the optimization of PG-encapsulated liposomes coated with HA has great potential for targeting several brain diseases.     

Dynamic Structural Transformation of Resveratrol‐Modified Stearate Liposomes Led to a Spontaneous Drug Release System

A mono‐substituted resveratrol derivative, resveratrol‐modified stearate (RMS), was synthesized by selectively coupling of stearic acid to the monohroxyphenyl of resveratrol in order to enhance both the stability and bioavailability of resveratrol. The RMS self‐assembles into liposomes and a series of suprastructural transformations into metastable helical ribbon, linear wire‐like structures, and inert spherical nanoparticles were detected that may be induced by the hydrogen‐bonding interactions. As a model for drug‐release investigations, gold nanoparticles (AuNPs) were encapsulated successfully by RMS to generate vesicles and succeed to release AuNPs druing the transformation to a ribbon‐like metastable stucture at ambient temperature.     

Pharmaceutical Development and Design of Thermosensitive Liposomes Based on the QbD Approach

This study aimed to produce thermosensitive liposomes (TSL) by applying the quality by design (QbD) concept. In this paper, our research group collected and studied the parameters that significantly impact the quality of the liposomal product. Thermosensitive liposomes are vesicles used as drug delivery systems that release the active pharmaceutical ingredient in a targeted way at ~40–42 °C, i.e., in local hyperthermia. This study aimed to manufacture thermosensitive liposomes with a diameter of approximately 100 nm. The first TSLs were made from DPPC (1,2-dipalmitoyl-sn-glycerol-3-phosphocholine) and DSPC (1,2-dioctadecanoyl-sn-glycero-3-phosphocholine) phospholipids. Studies showed that the application of different types and ratios of lipids influences the thermal properties of liposomes. In this research, we made thermosensitive liposomes using a PEGylated lipid besides the previously mentioned phospholipids with the thin-film hydration method.     

Development and validation of a mechanistic model for the release of embelin from a polycaprolactone matrix

Embelin is a natural agent with antimicrobial, antifungal and analgesic activities. This work presents a mechanistic model for the release of embelin from a polycaprolactone matrix. Based on the results of embelin release experiments and Raman microscopy measurements, the model assumes a dual dispersion of the embelin: agglomerated and dispersed. Embelin release mechanism combines the effects of the liquid migration into the matrix, the drug diffusion, and the drug dissolution within the wetted matrix. The model is formulated in terms of four partial differential equations that account for the mass balances of dispersed, agglomerated, and dissolved embelin, and aqueous solution. Model predictions show that the release mechanism involves three stages: a burst stage, in which dispersed embelin is rapidly released; a transition stage, in which dispersed and agglomerated embelin are simultaneously released; and, once the dispersed embelin depletion, a stable release stage until the agglomerated embelin exhausts.     

药用合成高分子缓、控释材料研究进展

药物的缓、控释材料可以实现药物的平稳长期的释放,同时使药物治疗达到有的放矢的效果,高分子材料是制作药物缓控释材料的重要材料,包括天然高分子与合成高分子两大类。其中,天然高分子用作药物缓控释材料的研究已有多年的历史,已为人们所熟知。本文主要综述药用合成高分子缓、控释材料研究进展,分析了不同缓、控释材料的制备方法、释药原理和适用药物,为合成新型药用缓、控释材料,扩大药用缓、控释高分子材料的应用范围提供依据。     

用于小动物活体的荧光-光热双模成像系统

报道了一种小动物活体荧光-光热双模成像系统, 其兼具荧光成像和热成像双功能, 具有成像灵敏度高、 采集速度快(≤51 frame/s)、 组织穿透深度大(近红外荧光成像时可达10 mm)以及0.1 ℃的热成像分辨率. 该系统不但能够实现小动物皮下肿瘤和深层组织/器官的荧光成像, 同时集成了热成像, 可实时监测光热治疗中的温度变化以及药物的控制释放过程, 有助于实现精准治疗.